BD² Seeks Additional Clinic Sites for Multidisciplinary Initiative to Advance Understanding of Bipolar Disorder

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire BD² Seeks Additional Clinic Sites for Multidisciplinary Initiative to Advance Understanding of Bipolar DisorderAuthor of the article:Awards of up to $2.35 million USD over five years available per clinic site.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountWashington, D.C., Sept. 29, 2026 (GLOBE NEWSWIRE) — Highlights:Expanding Existing Infrastructure: The BD² Integrated Network currently spans 11 clinical institutions across the U.S. and Canada, and is looking to add more sites.New Funding Announced: BD² is launching its third round of funding for new sites in its Integrated Network. Proposals are open to public, private, non-profit, and for-profit organizations in the U.S., Canada, and the U.K. providing clinical care for people with bipolar disorder. Selected sites will receive up to $2.35 million USD over five years.This advertisement has not loaded yet, but your article continues below.Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) today announced its third call for applications for clinical sites to join the BD² Integrated Network. The BD² Integrated Network currently spans 11 leading clinical institutions across the United States and Canada. It uniquely combines a traditional longitudinal cohort study of participants designed to generate in-depth phenotypes of bipolar disorder over time, and a learning health network aimed to iteratively improve care outcomes for people with bipolar disorder.In March 2026, the BD² Integrated Network released the first dataset from the Integrated Network, combining clinical, biological, neuroimaging, and real-world behavioral data from 615 participants across the network’s initial six sites, forming the most comprehensive multimodal dataset ever created for a psychiatric condition. The BD² Integrated Network is now expanding to include more clinic sites, with the plan to collect more longitudinal data and drive improvements in care for people with bipolar disorder.This request for applications (RFA) seeks eligible organizations to establish new Integrated Network clinic sites. Proposals will be accepted from any United States (including U.S. territories), Canada, or United Kingdom-based public or private-sector organization — including non-profit and for-profit organizations — that provides clinical care for people with bipolar disorder. Applicants can request up to $2.35 million each over five years. Submissions are due January 15, 2027, with awardees notified in May 2027 and an expected start date of June 2027.“We’re thrilled to expand the Integrated Network to additional clinic sites,” said Emily Baxi, PhD, Director of Clinical Transformation at BD². “Every new site brings us closer to the scale and the diversity we need — not just to advance the science, but to make sure that translates into better care for people with bipolar disorder.”New clinic sites will contribute to both components of the BD² Integrated Network, including the Longitudinal Cohort Study and the Learning Health Network. BD² is seeking team-oriented investigators committed to its vision of building adaptive, networked approaches to mental health care and research. Interested organizations are encouraged to apply before the January 15, 2027 deadline.For more information and how to apply, visit the BD² RFA Opportunities page.About BD² Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) is an independent nonprofit organization and the first organization focused on funding and advancing research and care for bipolar disorder on a global scale. Our collaborative, open-science approach is designed to transform and shorten the time it takes for scientific breakthroughs to make a meaningful difference in the lives of the tens of millions of people with bipolar disorder. The BD² Discovery Grants, Brain Omics, Genetics Platforms, and the Integrated Network are designed to share data, methods, and resources across initiatives and the bipolar disorder research community. For more information, please visit bipolardiscoveries.org.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againPatricia Pope BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder 5713274870 bd2@gmmb.com This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.